JANUX THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.1 USD | -0.86% |
|
-9.32% | +338.96% |
| May. 08 | Wedbush Raises Janux Therapeutics' PT to $74 From $53, Keeps Outperform Rating | MT |
| May. 08 | Janux Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Janux Therapeutics, Inc.
ddeabc278eddfd468.EEAnrCAh_L3MbiRI-9t9lku746OxlPIwwz-CpownSBo.ejpJnUhYtNz9N3c-zKoN8xvjpfzUy51Au1P0k91-PkV1ARPOFxmUyr02EA~a59b30d4728e10b4f50fe273e66d8e4f
Upcoming events on Janux Therapeutics, Inc.
Past events on Janux Therapeutics, Inc.
| 2024-05-07 04:01 pm | Q1 2024 Earnings Release |
| 2024-03-08 04:01 pm | Q4 2023 Earnings Release |
| 2024-02-26 04:30 pm | Business Update Call |
| 2023-11-07 04:01 pm | Q3 2023 Earnings Release |
| 2023-08-16 | H.C. Wainwright Immune Cell Engager Virtual Conference |
| 2023-08-08 04:01 pm | Q2 2023 Earnings Release |
| 2023-07-17 04:00 pm | PSMA-TRACTr JANX007 Phase 1a Clinical Update Call |
| 2023-06-14 04:00 pm | Annual General Meeting |
| 2023-05-10 05:00 pm | Bank of America Healthcare Conference |
| 2023-05-09 04:01 pm | Q1 2023 Earnings Release |
| 2023-05-02 08:00 am | H.C. Wainwright BioConnect Investor Conference |
| 2023-03-10 04:01 pm | Q4 2022 Earnings Release |
| 2023-03-06 09:10 am | Cowen Health Care Conference - Panel |
| 2022-11-30 12:35 pm | Evercore ISI HealthCONx Conference |
| 2022-11-29 08:50 am | Piper Sandler Healthcare Conference |
| 2022-11-11 03:10 pm | Cowen IO Next Summit |
| 2022-11-10 04:01 pm | Q3 2022 Earnings Release |
| 2022-09-12 07:00 am | H.C. Wainwright Global Investment Conference |
| 2022-09-06 | Citi BioPharma Conference |
| 2022-08-09 04:01 pm | Interim 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 3,64 2,08 74.83% | 8,61 6,56 31.37% | 8,08 6,36 27.18% | 3,14 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -32,8 -32,9 0.33% | -66,3 -73,8 10.18% | -71,0 -77,2 7.95% | -100 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -32,9 -32,1 -2.69% | -67,1 -69,7 3.68% | -73,0 -76,1 4.13% | -93,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -32,7 -31,6 -3.36% | -63,1 -66,6 5.26% | -59,3 -67,3 11.84% | -69,0 |
|
Net income Million USD | Released Forecast Spread | -6,78 | -32,7 -32,0 -2.23% | -63,1 -67,6 6.73% | -59,3 -67,3 11.84% | -74,3 |
|
EPS USD | Released Forecast Spread | -7,42 | -1,39 -1,36 -1.96% | -1,52 -1,64 7.09% | -1,32 -1,53 13.5% | -1,37 |
| Announcement Date | 16/04/21 | 18/03/22 | 10/03/23 | 08/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,59 0,81 96.08% | 2,37 0,85 178.86% | 1,81 0,74 144.15% | 2,85 0,81 253.2% | 2,05 0,67 204.6% | 1,06 0,88 20.8% | 2,52 0,85 197.69% | 2,46 0,74 232.9% | 1,25 1,02 23.01% | 0,63 | 0,71 | 0,58 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -15,6 -21,0 25.76% | |||||||||||||
|
EBIT Million USD | Released Forecast Spread | -13,5 -15,1 10.08% | -17,3 -15,0 -15.14% | -18,0 -20,3 11.06% | -18,3 -20,8 12.34% | -20,3 -20,8 2.45% | -20,7 -22,6 8.14% | -15,8 -21,9 27.65% | -16,1 -19,3 16.34% | -20,2 -20,1 -0.43% | -22,6 | -23,9 | -25,7 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,4 -15,1 11.36% | -16,9 -15,1 -11.91% | -16,7 -19,4 13.99% | -16,1 -19,0 15.37% | -17,5 -21,2 17.71% | -17,5 -21,9 20.07% | -11,6 -21,0 44.87% | -11,8 -18,2 35.24% | -14,8 -17,8 16.85% | -14,5 | -15,3 | -16,7 | ||
|
Net income Million USD | Released Forecast Spread | -13,4 -15,1 11.24% | -16,9 -15,1 -11.91% | -16,7 -20,2 17.52% | -16,1 -20,2 20.4% | -17,5 -20,3 13.89% | -17,5 -21,8 19.75% | -11,6 -21,0 44.87% | -11,8 -18,2 35.24% | -14,8 -18,5 20.05% | -16,9 | -17,8 | -19,9 | ||
|
EPS USD | Released Forecast Spread | -0,32 -0,37 12.73% | -0,41 -0,36 -13.89% | -0,40 -0,49 17.81% | -0,39 -0,49 20% | -0,42 -0,49 13.7% | -0,42 -0,52 18.84% | -0,25 -0,47 46.81% | -0,25 -0,41 39.02% | -0,30 -0,34 12.2% | -0,32 | -0,35 | -0,39 | -0,34 | -0,35 |
| Announcement Date | 10/05/22 | 09/08/22 | 10/11/22 | 10/03/23 | 09/05/23 | 08/08/23 | 07/11/23 | 08/03/24 | 08/05/24 | - | - | - | - | - |
| 2024-05-20 | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Janux Therapeutics, Inc.
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
| 2024-05-13 | POLARIS GROUP: Q1 2024 Earnings Release |
| 2024-05-13 04:30 pm | AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-13 07:00 am | APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-12 07:00 pm | PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- JANX Stock
- Calendar Janux Therapeutics, Inc.
